Article
Rottlerin as a therapeutic approach in psoriasis: Evidence from in vitro and in vivo studies
22 Dec 2017
Abstract excerpt
Rottlerin is a natural polyphenolic compound that was initially indicated as a PKCδ inhibitor. However, it was recently revealed that it may target a number of molecules and have biological effects on various cell types and is considered as a possible agent for tumor and cell proliferative diseases. Psoriasis is a chronic inflammatory cutaneous disorder with undefined etiology and is characterized by abnormal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
